PubMed HealthSearch

PubMed · 6985116

[Diffuse nonautoimmune hyperthyroidism].

Abstract

Diffuse non auto-immune hyperthyroidism is a rare entity, classically restricted to cases with hypersecretion of TSH, hCG or related molecule and to a few reports of proven paraneoplastic origin. The authors try to individualize another type of diffuse hyperthyroidism, previously considered to belong to Graves' disease, but without any sign of disimmunity. They present a familial form with several hyperthyroidic patients who showed neither change in humoral immunity nor immunological abnormality within the thyroid gland, even in those that were operated upon without prior antithyroid medication. Similar findings occurred within several series of hyperthyroid glands separately studied by the authors, using different techniques: histomorphometric quantification of lymphocytic infiltration, immunofluorescence in the search of IgG, IgA, IgM, C1 q, C3 and C9 fractions, or T-lymphocyte subsets. These techniques generally tend to yield positive results, that agree with an auto-immune pathogenesis, but totally negative findings do occur. This type of diffuse hyperthyroidism should be delineated from the common auto-immune type, and might be called toxic hyperplasia.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Leclere, J L Thomas. 1982. [Diffuse nonautoimmune hyperthyroidism].. https://pubmed.ncbi.nlm.nih.gov/6985116/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Genetic immunization--"the biological equivalent of cold fusion"?].

Genetic immunization is a new vaccine technology, where antigen encoding DNA plasmids are directly injected into muscle or skin with the purpose of eliciting an immune response to the gene product. The gene products are correctly glycosylated, folded and expressed by the host cell. This is an advantage when the antigens are difficult to obtain in the desired purity, amount or correctly glycosylated form or when only the genetic sequences are known e.g. HCV. The DNA plasmids are injected into muscles or delivered coated onto gold microparticles into the skin by a particle bombardment device, a "gene gun". Genetic immunization has demonstrated induction of both a specific humoral but also a more broadly reacting cellular immune response in animal models of cancer, mycoplasma, TB, malaria, and many virus infections including influenza and HIV. Thus, the DNA vaccine mimics a live vaccine without the biohazard. Many animal species have responded to genetic immunization and gene vaccine has also been used to induce a desired immuneresponse in patients with cancer and HIV. The technique was first described in 1992 but is developing fast. This review describes the history and principle of the technology, its advantages, problems and possible applications.

Antibody Formation